Brockow K - Search Results

1

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.

Valent P, Bonadonna P, Hartmann K, Broesby-Olsen S, Brockow K, Butterfield JH, Triggiani M, Lyons JJ, Oude Elberink JNG, Arock M, Metcalfe DD, Akin C. Valent P, et al. Among authors: brockow k. Int Arch Allergy Immunol. 2019;180(1):44-51. doi: 10.1159/000501079. Epub 2019 Jun 28. Int Arch Allergy Immunol. 2019. PMID: 31256161 Free PMC article. Review.

2

Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium.

Brockow K, Vieluf D, Püschel K, Grosch J, Ring J. Brockow K, et al. J Allergy Clin Immunol. 1999 Jul;104(1):237-8. doi: 10.1016/s0091-6749(99)70141-7. J Allergy Clin Immunol. 1999. PMID: 10400867 No abstract available.

3

Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.

Brockow K, Akin C, Huber M, Scott LM, Schwartz LB, Metcalfe DD. Brockow K, et al. J Allergy Clin Immunol. 2002 Jan;109(1):82-8. doi: 10.1067/mai.2002.120524. J Allergy Clin Immunol. 2002. PMID: 11799370

4

Generalized erythematous macules and plaques associated with flushing, repeated syncope, and refractory anemia.

Simpson JK, Brockow K, Turner ML, Akin C, Metcalfe DD. Simpson JK, et al. Among authors: brockow k. J Am Acad Dermatol. 2002 Apr;46(4):588-90. doi: 10.1067/mjd.2002.120446. J Am Acad Dermatol. 2002. PMID: 11907513 No abstract available.

5

Mastocytosis.

Brockow K, Metcalfe DD. Brockow K, et al. Curr Opin Allergy Clin Immunol. 2001 Oct;1(5):449-54. doi: 10.1097/01.all.0000011059.59188.08. Curr Opin Allergy Clin Immunol. 2001. PMID: 11964726 Review.

6

Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease.

Brockow K, Scott LM, Worobec AS, Kirshenbaum A, Akin C, Huber MM, Metcalfe DD. Brockow K, et al. Arch Dermatol. 2002 Jun;138(6):785-90. doi: 10.1001/archderm.138.6.785. Arch Dermatol. 2002. PMID: 12056960

7

Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology.

Brockow K, Akin C, Huber M, Metcalfe DD. Brockow K, et al. J Am Acad Dermatol. 2003 Apr;48(4):508-16. doi: 10.1067/mjd.2003.98. J Am Acad Dermatol. 2003. PMID: 12664011

8

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit.

Akin C, Brockow K, D'Ambrosio C, Kirshenbaum AS, Ma Y, Longley BJ, Metcalfe DD. Akin C, et al. Among authors: brockow k. Exp Hematol. 2003 Aug;31(8):686-92. doi: 10.1016/s0301-472x(03)00112-7. Exp Hematol. 2003. PMID: 12901973 Free article.

9

Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a.

Woolhiser MR, Brockow K, Metcalfe DD. Woolhiser MR, et al. Among authors: brockow k. Clin Immunol. 2004 Feb;110(2):172-80. doi: 10.1016/j.clim.2003.11.007. Clin Immunol. 2004. PMID: 15003814

10

IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis.

Brockow K, Akin C, Huber M, Metcalfe DD. Brockow K, et al. Clin Immunol. 2005 May;115(2):216-23. doi: 10.1016/j.clim.2005.01.011. Clin Immunol. 2005. PMID: 15885646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters